MXCT

MAXCYTE INC COM STK USD0.01 (DI)

TitleTime
Result of Special Meeting and Issue of EquityThu 21/05/20 | 13:50
Poster Presentation on MCY-M11 at ASCO 2020Thu 14/05/20 | 07:00
License Agreement with Caribou BiosciencesThu 07/05/20 | 07:00
Result of OfferingFri 01/05/20 | 07:00
Proposed Offering to raise up to £25.1 millionThu 30/04/20 | 17:39
Final Results for Year Ended 31 December 2019Tue 21/04/20 | 07:00
Business Update Related to COVID-19 PandemicThu 09/04/20 | 07:00
License Agreement with Allogene TherapeuticsTue 24/03/20 | 07:00
Consolidation of Trading LinesFri 21/02/20 | 07:00
AIM Block Admission Return / Total Voting RightsThu 20/02/20 | 18:18
Grant Of OptionsFri 24/01/20 | 16:31
Holding(s) in CompanyWed 22/01/20 | 17:15
Holding(s) in CompanyWed 22/01/20 | 17:11
Holding(s) in CompanyWed 22/01/20 | 17:08
Trading UpdateMon 20/01/20 | 07:00
New Executive Vice President and Trial UpdateThu 19/12/19 | 07:00
Director/PCA transaction initial notificationMon 16/12/19 | 17:25
Agreement with KSQ TherapeuticsWed 04/12/19 | 07:00
Vor Biopharma Clinical and Commercial LicenseThu 21/11/19 | 07:00
Result of AGMFri 01/11/19 | 13:04
MaxCyte Advances Phase I Clinical TrialThu 24/10/19 | 07:00
Notification of AGM and Audit DeclarationTue 08/10/19 | 07:00
Editas Clinical and Commercial License AgreementMon 07/10/19 | 07:00
Updates on CARMA Platform at Upcoming MeetingsMon 30/09/19 | 07:00
Results for the Six Months ended 30 June 2019Wed 18/09/19 | 07:00
Notice of ResultsWed 14/08/19 | 07:00
Trading UpdateWed 17/07/19 | 07:00
MaxCyte to Host Capital Markets Day TodayThu 11/07/19 | 07:00
Second Price Monitoring ExtnFri 05/07/19 | 16:42
Price Monitoring ExtensionFri 05/07/19 | 16:36
Annual ReportWed 19/06/19 | 07:00
Appointment of Joint Corporate BrokerWed 12/06/19 | 07:00
Second Price Monitoring ExtnWed 08/05/19 | 16:41
Price Monitoring ExtensionWed 08/05/19 | 16:36
Phase I Clinical Trial of MCY-M11 ProgressedWed 08/05/19 | 07:00
Final Results for Year Ended 31 December 2018Wed 24/04/19 | 07:00
Launch of ExPERTT Instrument FamilyMon 08/04/19 | 07:00
Notice of Full Year ResultsTue 26/03/19 | 07:00
Director DealingsTue 19/03/19 | 17:05
Grant of OptionsTue 05/03/19 | 07:00
Clinical & Commercial Agreement with KiteFri 01/03/19 | 07:00
Result of Special Meeting and Issue of EquityTue 26/02/19 | 17:32
Results of PlacingTue 05/02/19 | 16:32
Proposed Placing to raise a minimum of £10 millionTue 05/02/19 | 07:00
Trading UpdateTue 15/01/19 | 07:00
Change of AuditorWed 19/12/18 | 07:00
Director DealingsMon 17/12/18 | 18:06
Consolidation of Trading LinesWed 21/11/18 | 07:00
Block Admission Six Monthly Return/TVRTue 20/11/18 | 07:00
Webinar: non-viral cell engineeringFri 16/11/18 | 07:00
Clinical and Commercial License AgreementWed 14/11/18 | 07:00
MaxCyte Announces Research Agreement with KiteMon 12/11/18 | 07:00
Expansion of CRISPR Commercial License AgreementFri 09/11/18 | 07:00
Result of AGMWed 31/10/18 | 16:25
Dosing Begins in First Clinical Trial of MCY-M11Wed 10/10/18 | 07:00
Notice of AGMMon 08/10/18 | 07:00
Results for the Half Year ended 30 June 2018Mon 24/09/18 | 07:00
Grant of OptionsMon 10/09/18 | 07:00
Notice of Half Year ResultsMon 03/09/18 | 07:00
Director/PDMR ShareholdingThu 26/07/18 | 17:33
Trading UpdateMon 16/07/18 | 07:00
FDA IND Clearance for First Clinical ProgrammeMon 16/07/18 | 07:00
Notice of AGM and Annual ReportMon 30/04/18 | 07:00
Final Results for Year Ended 31 December 2017Wed 04/04/18 | 07:00
Notice of Full Year ResultsThu 15/03/18 | 07:00
Director/PDMR ShareholdingWed 28/02/18 | 17:00
Grant of OptionsThu 15/02/18 | 07:00
Dr Richard Douglas Joins MaxCyte BoardTue 13/02/18 | 07:00
Block listing Interim ReviewThu 01/02/18 | 16:06
Total Voting RightsTue 23/01/18 | 13:32
Trading UpdateMon 22/01/18 | 07:00
Total Voting RightsFri 12/01/18 | 17:13
Total Voting RightsThu 30/11/17 | 15:26
Result of AGMTue 31/10/17 | 12:47
Declaration of Audit RemunerationMon 16/10/17 | 07:00
Holding(s) in CompanyThu 05/10/17 | 18:32
Holding(s) in CompanyThu 05/10/17 | 18:31
Notice of AGMThu 28/09/17 | 17:15
Interim ResultsTue 19/09/17 | 07:00
Notice of Half Year ResultsFri 25/08/17 | 07:00
Grant of OptionsThu 20/07/17 | 18:02
Trading UpdateWed 12/07/17 | 07:00